Literature DB >> 34513285

Heuristic scoring method utilizing FDG-PET statistical parametric mapping in the evaluation of suspected Alzheimer disease and frontotemporal lobar degeneration.

Jeremy N Ford1, Elizabeth M Sweeney2, Myrto Skafida3, Shannon Glynn3, Michael Amoashiy4, Dale J Lange5, Eaton Lin3, Gloria C Chiang3, Joseph R Osborne3, Silky Pahlajani4, Mony J de Leon3, Jana Ivanidze3.   

Abstract

Distinguishing frontotemporal lobar degeneration (FTLD) and Alzheimer Disease (AD) on FDG-PET based on qualitative review alone can pose a diagnostic challenge. SPM has been shown to improve diagnostic performance in research settings, but translation to clinical practice has been lacking. Our purpose was to create a heuristic scoring method based on statistical parametric mapping z-scores. We aimed to compare the performance of the scoring method to the initial qualitative read and a machine learning (ML)-based method as benchmarks. FDG-PET/CT or PET/MRI of 65 patients with suspected dementia were processed using SPM software, yielding z-scores from either whole brain (W) or cerebellar (C) normalization relative to a healthy cohort. A non-ML, heuristic scoring system was applied using region counts below a preset z-score cutoff. W z-scores, C z-scores, or WC z-scores (z-scores from both W and C normalization) served as features to build random forest models. The neurological diagnosis was used as the gold standard. The sensitivity of the non-ML scoring system and the random forest models to detect AD was higher than the initial qualitative read of the standard FDG-PET [0.89-1.00 vs. 0.22 (95% CI, 0-0.33)]. A categorical random forest model to distinguish AD, FTLD, and normal cases had similar accuracy than the non-ML scoring model (0.63 vs. 0.61). Our non-ML-based scoring system of SPM z-scores approximated the diagnostic performance of a ML-based method and demonstrated higher sensitivity in the detection of AD compared to qualitative reads. This approach may improve the diagnostic performance. AJNMMI
Copyright © 2021.

Entities:  

Keywords:  Alzheimer; Dementia; FDG-PET; FTLD; SPM

Year:  2021        PMID: 34513285      PMCID: PMC8414399     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  57 in total

1.  Classification of Alzheimer's disease from FDG-PET images using favourite class ensembles.

Authors:  Carlos Cabral; Margarida Silveira
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2013

Review 2.  ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Authors:  Nadja Smailagic; Marco Vacante; Chris Hyde; Steven Martin; Obioha Ukoumunne; Christos Sachpekidis
Journal:  Cochrane Database Syst Rev       Date:  2015-01-28

3.  Clinical course of primary progressive aphasia: clinical and FDG-PET patterns.

Authors:  Jordi A Matias-Guiu; María Nieves Cabrera-Martín; Teresa Moreno-Ramos; Rocío García-Ramos; Jesús Porta-Etessam; José Luis Carreras; Jorge Matías-Guiu
Journal:  J Neurol       Date:  2014-12-10       Impact factor: 4.849

4.  Cerebral glucose metabolism in patients with frontotemporal dementia.

Authors:  K Ishii; S Sakamoto; M Sasaki; H Kitagaki; S Yamaji; M Hashimoto; T Imamura; T Shimomura; N Hirono; E Mori
Journal:  J Nucl Med       Date:  1998-11       Impact factor: 10.057

5.  Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies.

Authors:  Juergen Dukart; Karsten Mueller; Annette Horstmann; Barbara Vogt; Stefan Frisch; Henryk Barthel; Georg Becker; Harald E Möller; Arno Villringer; Osama Sabri; Matthias L Schroeter
Journal:  Neuroimage       Date:  2009-09-18       Impact factor: 6.556

6.  Evaluation of Atlas-Based Attenuation Correction for Integrated PET/MR in Human Brain: Application of a Head Atlas and Comparison to True CT-Based Attenuation Correction.

Authors:  Tetsuro Sekine; Alfred Buck; Gaspar Delso; Edwin E G W Ter Voert; Martin Huellner; Patrick Veit-Haibach; Geoffrey Warnock
Journal:  J Nucl Med       Date:  2015-10-22       Impact factor: 10.057

7.  Z-score maps from low-dose 18F-FDG PET of the brain in neurodegenerative dementia.

Authors:  David Fällmar; Johan Lilja; Torsten Danfors; Lena Kilander; Victor Iyer; Mark Lubberink; Elna-Marie Larsson; Jens Sörensen
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-08-20

8.  Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting.

Authors:  Daniela Perani; Pasquale Anthony Della Rosa; Chiara Cerami; Francesca Gallivanone; Federico Fallanca; Emilia Giovanna Vanoli; Andrea Panzacchi; Flavio Nobili; Sabina Pappatà; Alessandra Marcone; Valentina Garibotto; Isabella Castiglioni; Giuseppe Magnani; Stefano F Cappa; Luigi Gianolli
Journal:  Neuroimage Clin       Date:  2014-10-24       Impact factor: 4.881

9.  Automated Online Quantification Method for 18F-FDG Positron Emission Tomography/CT Improves Detection of the Epileptogenic Zone in Patients with Pharmacoresistant Epilepsy.

Authors:  Vanessa Cristina Mendes Coelho; Marcia E Morita; Barbara J Amorim; Celso Darío Ramos; Clarissa L Yasuda; Helder Tedeschi; Enrico Ghizoni; Fernando Cendes
Journal:  Front Neurol       Date:  2017-09-01       Impact factor: 4.003

10.  FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.

Authors:  Silvia Paola Caminiti; Tommaso Ballarini; Arianna Sala; Chiara Cerami; Luca Presotto; Roberto Santangelo; Federico Fallanca; Emilia Giovanna Vanoli; Luigi Gianolli; Sandro Iannaccone; Giuseppe Magnani; Daniela Perani
Journal:  Neuroimage Clin       Date:  2018-01-28       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.